Analysing UiPath Stock: Does Accelerating Revenue Make It a Buy?UiPath, Inc. Class ABATS:PATHKalaGhaziUiPath (NYSE: PATH) continues to struggle in the market, with its share price currently trading more than 25% lower than where it stood at the beginning of the year. Even though the company has recently demonstrated some modest signs of recovery, it has been heavily impacted by the broader sell-off affecting software-as-a-service (SaaS) stocks. UiPath specializes in automation solutions, primarily using software-based bots and orchestration platforms designed to support agentic artificial intelligence. Building Momentum, Though Gradually In its most recent first-quarter earnings report, UiPath managed to generate some positive, albeit still relatively restrained, momentum. The company has made agentic AI orchestration a central priority, noting that AI-related products were part of 16 out of its 20 largest deals completed during the quarter. Furthermore, on average, deals involving AI were six times larger in value than those that did not include AI products. UiPath also continues to perform well among its established customer base. The company reported a dollar-based net retention rate of 109% over the past twelve months, an improvement from the 107% recorded in the previous quarter. A retention rate above 100% indicates that existing customers are increasing their spending with the company after a period of customer attrition. Additionally, new annual recurring revenue (ARR) for the quarter amounted to $49 million. Should Investors Consider Buying? Despite delivering a solid quarterly performance, UiPath issued a cautious outlook for the second quarter, citing some currency-related headwinds as a contributing factor to its conservative guidance. While the stock currently appears inexpensive—trading at a forward price-to-sales ratio of just 3.5 and a forward price-to-earnings ratio of approximately 14.5—the company still needs to demonstrate a more significant acceleration in ARR growth before the stock can deliver a sustained recovery and become a more compelling buy for investors.